Head Of National Cancer Institute Will Temporarily Take Over FDA

This 2015 photo made available by the Feature Photo Service for IBM shows Dr. Norman Sharpless, director of the University of North Carolina Lineberger Comprehensive Cancer Center, examines DNA sequencing data in Cha... This 2015 photo made available by the Feature Photo Service for IBM shows Dr. Norman Sharpless, director of the University of North Carolina Lineberger Comprehensive Cancer Center, examines DNA sequencing data in Chapel Hill, N.C. On Tuesday, March 12, 2019, The Food and Drug Administration announced that Sharpless will temporarily take charge of the agency next month after the departure of its current chief, Scott Gottlieb. (Jared Lazarus/Feature Photo Service for IBM via AP) MORE LESS
Start your day with TPM.
Sign up for the Morning Memo newsletter

WASHINGTON (AP) — The head of the National Cancer Institute will temporarily take charge of the Food and Drug Administration next month after the departure of its current chief.

The appointment Tuesday of Dr. Ned Sharpless comes a week after Scott Gottlieb unexpectedly announced his resignation.

Sharpless currently heads the National Institutes of Health’s cancer division, which directs billions in federal funding and grants for research. His name has been circulated as one of several government officials likely to succeed Gottlieb on a permanent basis.

Health and Human Services Secretary Alex Azar said the search for a new FDA commissioner is underway.

The FDA’s top official is nominated by the president and must be confirmed by the Senate, typically following public hearings before health lawmakers.

Last Tuesday, Gottlieb said he would step in down in April after less than two years leading the FDA, a massive public health agency that regulates the food, drug, medical device and tobacco industries, among others. He was widely viewed as one of President Donald Trump’s most effective administrators, serving as a key messenger on the federal response to rising drug prices, the opioid epidemic and underage of use e-cigarettes.

Gottlieb said he wants to spend more time with his family after commuting weekly to Washington from his home in Connecticut.

During his tenure, Gottlieb launched a series of ambitious public health initiatives, including a plan to make cigarettes less addictive by drastically cutting nicotine levels. But that plan and many others have barely progressed beyond the earliest stages, raising questions about their timeline and prospects for completion. FDA commissioners report to the White House, but generally have broad leeway to choose their priorities.

Sharpless has publicly supported FDA’s efforts to more tightly regulate tobacco and crack down on underage vaping. E-cigarettes are generally viewed as less harmful than traditional tobacco products, but they usually contain nicotine which can harm the adolescent brain. Some research also suggests that teenagers who use e-cigarettes are more likely to try regular cigarettes.

Sharpless has led the National Cancer Institute since October 2017. He previously was a professor and administrator at the University of North Carolina, where he also earned his medical degree in 1993.

Latest News

Notable Replies

  1. The FDA is becoming too complex to fly.

  2. Oh goodie…we have another ‘TEMP’ cabinet member…or a ‘tryout’ period. This way Trump can kick them out if they don’t pay fealty and pretend they aren’t one of the revolving door of ‘the best people’.

  3. Sarah, is there any truth to the rumor that Dr. Ned Sharpless is a scientist?

  4. “Gottlieb said he wants to spend more time with his family…”

    "Family" is a vastly overrated way to spend your time.
  5. Are there any “permanent “ high level types left in donnie’s Admin?

Continue the discussion at forums.talkingpointsmemo.com

5 more replies

Participants

Avatar for system1 Avatar for sysprog Avatar for steviedee111 Avatar for christianhankel Avatar for left_in_washington_state Avatar for riverstreet Avatar for hoagie Avatar for surge Avatar for seamus42 Avatar for outis

Continue Discussion
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Deputy Editor:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: